Sort by
Refine Your Search
-
Listed
-
Program
-
Field
-
on the clinical and economic impact of Pfizer Oncology medicines and products. The colleague may help inform customer decision-making and improve population health through real-world data analyses, pharmacoeconomic
-
to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review
-
internally and externally-facing medical channels, including scientific communication platforms (SCPs), publications, plain language summaries (PLS), congress narratives/content, advisory board content
-
making and implementation. Provide education on the clinical and economic impact to help inform customer decision-making and improve population health through the communication of real-world data analyses
-
health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which
-
making and implementation. Provide education on the clinical and economic impact to help inform customer decision-making and improve population health through the communication of real-world data analyses
-
government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and
-
regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure
-
-functional integration with stakeholders at the global and local levels (e.g. research and development, health outcomes, commercial, regulatory, safety, public affairs); lead execution of evidence and insight
-
-functional integration with stakeholders at the global and local levels (e.g. research and development, health outcomes, commercial, regulatory, safety, public affairs); lead execution of evidence and insight